CANIDRYL 20 MG TABLETS FOR DOGS
Država: Irska
Jezik: engleski
Izvor: HPRA (Health Products Regulatory Authority)
Svojstava lijeka
(SPC)
03-05-2024
Neki dokumenti za ovaj proizvod trenutno nisu dostupni, možete poslati zahtjev u našu korisničku službu i mi ćemo vas obavijestiti čim ih budemo mogli dobiti.
Pošalji zahtjev.
Pošalji zahtjev.
Aktivni sastojci:
CARPROFEN
Dostupno od:
Chanelle Pharmaceuticals Manufacturing Limited
ATC koda:
QM01AE91
INN (International ime):
CARPROFEN
Doziranje:
20 Milligram
Farmaceutski oblik:
Tablets
Tip recepta:
POM
Terapijska grupa:
Canine
Područje terapije:
Carprofen
Terapijske indikacije:
N.S.A.I.D
Status autorizacije:
Authorised
Datum autorizacije:
2006-03-03
Svojstava lijeka
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Canidryl 20 mg Tablets for dogs.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE INGREDIENT
Carprofen 20.0 mg/tablet
EXCIPIENTS
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Tablet.
A plain round flat bevelled edge white tablet with a breakline on one side. The tablets can be divided into equal halves.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Reduction of inflammation and pain caused by musculo-skeletal disorders and degenerative joint disease. As a follow
up to parenteral analgesia in the management of post-operative pain.
4.3 CONTRAINDICATIONS
Do not use in cats.
Do not use in pups less than 4 months of age.
Do not use in case of hypersensitivity to active substance or to any of the excipients.
Do not use in dogs suffering from cardiac, hepatic or renal disease, where there is a possibility of gastro-intestinal
ulceration or bleeding, or where there is evidence of a blood dyscrasia.
Refer to section 4.7.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Refer to Sections 4.3 and 4.5
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 30/08/2011_
_CRN 7010826_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Use in aged dogs, may involve additional risk. If such a use cannot be avoided, dogs may require careful clinical
management.
Avoid use in any dehydrated, hypovolaemic or hypotensive dog, as there is a potential risk of increased renal toxicity.
Concurrent administration of potential nephrotoxic drugs should be avoided.
NSAIDs can cause inhibition of phagocytosis and hence in the treatment
Pročitajte cijeli dokument
